Embracing Diversity & Inclusion
-
6 Practical Ways To Increase Diversity In Clinical Trials
6/11/2020
Even when a certain disease is more prevalent in a particular minority population, it can still be difficult for trial investigators to reach the right individuals. As an industry — as a group of researchers dedicating our lives to improve the health of others, regardless of their race, age, gender, or disease — how can we do better?
-
Diverse Enrollment In Clinical Trials: What Do Successful Research Sites Have In Common?
5/19/2020
Diverse enrollment in clinical research studies is a complex issue that has multifaceted implications for clinical research sites. An understanding of the research site community’s perceived awareness and current ability to enroll these populations is lacking in the clinical trials landscape.
-
How Do Underserved Communities Prefer To Learn About Clinical Research?
5/5/2020
It is important to look at the big picture and better understand core participation motivators and barriers from the underrepresented patient’s perspective in order to better enable access to and increase their participation in clinical trials.
-
Bridging The Chasm Between The Haves And The Have-Nots In Cancer Trials
4/9/2020
Clinical trials are the most important and reliable means available to provide scientific evidence for developing therapies and effective care management for patients. It is therefore essential to achieve diverse participation in clinical trials in order to ensure medical advancements — whether for testing or treating COVID-19 or for cancer therapeutics — are applicable to all populations.
-
4 Questions AbbVie Asked To Create More Diverse Clinical Trials
1/17/2020
Over the five years I have been at AbbVie, the idea of diversity and inclusivity in healthcare was especially relevant to our clinical trials in uterine fibroids. We successfully centered patients in our program by understanding their needs, concerns, and desires, which enabled us to recruit and retain women representative of the patient landscape in this disease state. How? We asked ourselves four important questions.
-
How Big Pharma Is Tackling Patient Centricity & Diversity Challenges In Clinical Trials
5/30/2017
There’s a lot of talk about patient centricity in the clinical trial arena these days, and for good reason — hearing the voice of patient and incorporating patient perspectives into trial design can pay huge dividends for all stakeholders involved. But what does it mean to be patient centric, practically speaking? What tactics are leading pharma companies employing to make centricity a reality in their trials?